High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

J. A. Child(Spanish Head & Neck Cancer Cooperative Group), Peter J. Selby(Centre for Addiction and Mental Health), Mark T. Drayson(Institute of Immunology), Roger G. Owen(Leeds Teaching Hospitals NHS Trust), Julia Brown(University of Leeds), Gareth J. Morgan(Hywel Dda University Health Board), Kim Hawkins(University of Leeds), Faith E. Davies(NYU Langone Health)
New England Journal of Medicine
May 7, 2003
10.1056/nejmoa022340
Cited by 1,764

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k